You just read:

New Real-World Analyses Support Effectiveness and Safety of Entyvio® (vedolizumab) for Ulcerative Colitis and Crohn's Disease

News provided by

Takeda Pharmaceutical Company Limited

May 08, 2017, 10:30 ET